BOCA RATON, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- Cleartronic, Inc., (OTCPINK:CLRI) announces its entrance into the explosive “Medical Cannabis Industry.”

Larry Reid, President of Cleartronic, stated, “Over the past several months, we have been researching all areas of the medical cannabis market, both nationally and internationally.  This is in line with creating a diversified company through both development and acquisition.  We have discovered that there are many areas of the medical cannabis market that we can participate in and bring value to our shareholders.” 

Reid continued, “Our efforts over many months traveling abroad, researching and selecting grow farm facilities and distribution channels for finished products have led our Board of Directors to approve our entering this growing industry that is still in its infancy.”

“We are moving rapidly, as we continue our research into obtaining government approvals, and currently negotiating agreements with strategic partners,” said Reid.  “When definitive agreements are reached, our shareholders and the public will be notified.  These advances will enhance shareholder value while expanding and diversifying our company goals.”

As more information about CLRI’s entrance into the “Medical Cannabis Industry” becomes available, timely updates will be provided.

About Cleartronic, Inc.

Cleartronic, Inc., a diversified holding Company, creates and acquires operating subsidiaries with the goal of manufacturing and selling products, services, and integrated systems to government agencies, business enterprises and the general public. In addition to its ongoing research and development projects, Cleartronic currently has two operating subsidiaries, ReadyOp Communications, Inc. and VoiceInterop, Inc. - www.cleartronic.comwww.voiceinterop.com and www.readyop.com.

Safe Harbor Statement

This news release contains statements that involve expectations, plans or intentions (such as those relating to future business or financial results) and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as "may," "should," "expect," "anticipate," "believe," "estimate," "intend," "plan" and other similar expressions. Our actual results could differ materially from those anticipated in these forward-looking statements because of certain factors not within the control of the company. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to finalize and enter into definitive agreements with strategic partners, the availability of additional funding, the early-stage nature of the industry sector; regulatory changes affecting the sale, transport or consumption of Cannabidiol or hemp based products by humans or animals, commercial impacts to the Company’s business, related agreements, product development, marketing and distribution plans and strategies.  The company cautions readers not to place undue reliance on any such forward-looking statements which speak only as of the date made. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Contact and Inquiries for Investor Relations:

Larry Reid
561-939-3300 Ext 143

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/cd306656-c7d4-4304-88c6-dc7550a0a619